Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gestational Diabetes and Pharmacotherapy (GAP)
Sponsor: Medical College of Wisconsin
Summary
The goal of this study is to compare two different thresholds for initiation of medical treatment for GDM. Pregnant women diagnosed with GDM will be randomized to either start pharmacotherapy when they have reached at least 20% or at least 40% of capillary blood glucose (CBG) values above the target goal. The investigators hypothesize that a lower threshold of 20% elevated CBG levels, compared to 40%, will lead to lower rates of obstetric and medical complications.
Official title: Gestational Diabetes and Pharmacotherapy (GAP) - A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients With Gestational Diabetes
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
416
Start Date
2021-05-04
Completion Date
2026-10-01
Last Updated
2026-03-24
Healthy Volunteers
No
Conditions
Interventions
Insulin
Insulin may be administered base on glucose log values. The dosing of the insulin will be determined by the provider using typical management of gestational diabetes.
Locations (1)
Medical College of Wisconsin
Milwaukee, Wisconsin, United States